BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11960392)

  • 21. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
    Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
    Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
    Byrd JC; Mrózek K; Dodge RK; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Patil SR; Rao KW; Watson MS; Koduru PR; Moore JO; Stone RM; Mayer RJ; Feldman EJ; Davey FR; Schiffer CA; Larson RA; Bloomfield CD;
    Blood; 2002 Dec; 100(13):4325-36. PubMed ID: 12393746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
    Grimwade D; Walker H; Oliver F; Wheatley K; Harrison C; Harrison G; Rees J; Hann I; Stevens R; Burnett A; Goldstone A
    Blood; 1998 Oct; 92(7):2322-33. PubMed ID: 9746770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
    J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.
    Schoch C; Haferlach T; Haase D; Fonatsch C; Löffler H; Schlegelberger B; Staib P; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
    Br J Haematol; 2001 Jan; 112(1):118-26. PubMed ID: 11167792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome.
    Jotterand Bellomo M; Parlier V; Mühlematter D; Grob JP; Beris P
    Cancer Genet Cytogenet; 1992 Apr; 59(2):138-60. PubMed ID: 1581880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features.
    Testoni N; Borsaru G; Martinelli G; Carboni C; Ruggeri D; Ottaviani E; Pelliconi S; Ricci P; Pastano R; Visani G; Zaccaria A; Tura S
    Haematologica; 1999 Aug; 84(8):690-4. PubMed ID: 10457403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
    Jarosová M; Indrák K; Holzerová M; Hubácek J; Faber E; Papajík T; Raida L; Szotkowski T; Knotková R; Hlusí T; Jedlicková K; Pikalová Z; Sulovská I
    Vnitr Lek; 2001 Sep; 47 Suppl 1():8-14. PubMed ID: 11693065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
    Grimwade D; Hills RK; Moorman AV; Walker H; Chatters S; Goldstone AH; Wheatley K; Harrison CJ; Burnett AK;
    Blood; 2010 Jul; 116(3):354-65. PubMed ID: 20385793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the long arm of chromosome 3 (3q) in malignant myeloid hemopathies. A study of 10 cases].
    Sancho JM; Granada I; Ribera JM; Batlle M; Hernández JA; Navarro JT; Fernández F; Millá F; Feliu E
    Med Clin (Barc); 1999 Apr; 112(13):499-502. PubMed ID: 10353117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
    Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
    Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
    Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).
    Kainz B; Heintel D; Marculescu R; Schwarzinger I; Sperr W; Le T; Weltermann A; Fonatsch C; Haas OA; Mannhalter C; Lechner K; Jaeger U
    Hematol J; 2002; 3(6):283-9. PubMed ID: 12522450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
    Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
    Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multipoint interphase FISH analysis of chromosome 3 abnormalities in 28 childhood AML patients.
    Haltrich I; Kost-Alimova M; Kovács G; Klein G; Fekete G; Imreh S
    Eur J Haematol; 2006 Feb; 76(2):124-33. PubMed ID: 16405433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3.
    Grigg AP; Gascoyne RD; Phillips GL; Horsman DE
    Br J Haematol; 1993 Jan; 83(1):158-65. PubMed ID: 8435325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
    Tavernier E; Le QH; Elhamri M; Thomas X
    Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.